Drug intelligence / Profile preview

pentamethylchromanol

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

**Pentamethylchromanol** (PMCol, APC-100) is a small molecule related to vitamin E, composed of a chromanol ring lacking the lipophilic phytyl tail, imparting higher water solubility. It functions as an androgen receptor antagonist and exhibits chemopreventive, antineoplastic, and antioxidant activities. PMCol was studied as an oral agent for the prevention and treatment of androgen-dependent cancers, notably prostate cancer. Its mechanism includes androgen receptor antagonism evidenced in LNCaP prostate carcinoma cells, with antioxidant protection of erythrocytes from free radical-induced hemolysis. Its metabolism varies across species. PMCol is distinguished by water solubility and purported advantages over vitamin E as a chemopreventive agent[1][3][11][12][13].

Brand names
APC-100APC100APC 100
Other names
2,2,5,7,8-pentamethyl-6-chromanol2,2,5,7,8-pentamethylchromanolpentamethyl-6-chromanolpentamethyl6-chromanolpentamethyl 6-chromanolpentamethylchromanol2,2,5,7,8-pentamethylchroman-6-ol2,2,5,7,8-pentamethyl-6-hydroxychroman2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-ol6-hydroxy-2,2,5,7,8-pentamethylchroman2,2,5,7,8-pentamethyl-3,4-dihydro-2H-1-benzopyran-6-ol2,2,2,5,7,8-pentamethyl-6-hydroxychroman
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on pentamethylchromanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pentamethylchromanol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call